• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ChEMBL 中配体-靶标相互作用数据的增长与化合物的普遍反应性(即与多种靶点相互作用的能力)的增加和基于活性的测量方法有关。

Growth of ligand-target interaction data in ChEMBL is associated with increasing and activity measurement-dependent compound promiscuity.

机构信息

Department of Life Science Informatics, B-IT, LIMES Program Unit Chemical Biology and Medicinal Chemistry, Rheinische Friedrich-Wilhelms-Universität, Dahlmannstr. 2, D-53113 Bonn, Germany.

出版信息

J Chem Inf Model. 2012 Oct 22;52(10):2550-8. doi: 10.1021/ci3003304. Epub 2012 Sep 28.

DOI:10.1021/ci3003304
PMID:22978710
Abstract

Compounds with high-confidence target annotations and activity measurements in the original and current release of the ChEMBL database have been compared to better understand how the growth of compound activity data might influence the spectrum of ligand-target interactions and the degree of target promiscuity among active compounds. Compared to the original ChEMBL release, a significant increase in the proportion of target promiscuous compounds was observed in the current version. The presence of these compounds led to large-magnitude changes in compound activity-based target and target family relationships and to a reorganization of major target communities. Surprisingly, however, this strong trend toward increasing target promiscuity was largely caused by growth of compounds with exclusive IC(50) measurements. By contrast, compounds with available equilibrium constants, which were also added in large amounts, did not substantially alter compound-based target relationships and notably contribute to increasing target promiscuity. These findings suggest that apparent compound promiscuity is much dependent on experimental conditions under which activities are determined and that care should be taken when evaluating promiscuity and polypharmacology on the basis of assay-dependent activity measurements.

摘要

与原始版本的 ChEMBL 数据库相比,对在 ChEMBL 数据库的原始和当前版本中具有高置信度靶标注释和活性测量值的化合物进行了比较,以便更好地了解化合物活性数据的增长如何影响配体-靶标相互作用的范围和活性化合物中靶标的混杂程度。与原始 ChEMBL 版本相比,当前版本中观察到靶标混杂化合物的比例显著增加。这些化合物的存在导致基于化合物活性的靶标和靶标家族关系发生了大幅度变化,并导致主要靶标群落的重新组织。然而,令人惊讶的是,这种靶标混杂性增加的强烈趋势主要是由于具有独特 IC(50)测量值的化合物的增长所致。相比之下,具有可用平衡常数的化合物(也大量添加)并没有实质性地改变基于化合物的靶标关系,并且显著有助于增加靶标混杂性。这些发现表明,明显的化合物混杂性在很大程度上取决于测定活性的实验条件,并且在基于依赖于测定的活性测量值评估混杂性和多效性时应谨慎。

相似文献

1
Growth of ligand-target interaction data in ChEMBL is associated with increasing and activity measurement-dependent compound promiscuity.ChEMBL 中配体-靶标相互作用数据的增长与化合物的普遍反应性(即与多种靶点相互作用的能力)的增加和基于活性的测量方法有关。
J Chem Inf Model. 2012 Oct 22;52(10):2550-8. doi: 10.1021/ci3003304. Epub 2012 Sep 28.
2
Activity profile relationships between structurally similar promiscuous compounds.结构相似的泛型化合物的活性谱关系。
Eur J Med Chem. 2013 Nov;69:393-8. doi: 10.1016/j.ejmech.2013.08.044. Epub 2013 Sep 12.
3
What is the likelihood of an active compound to be promiscuous? Systematic assessment of compound promiscuity on the basis of PubChem confirmatory bioassay data.一种活性化合物具有混杂性的可能性有多大?基于 PubChem 确证性生物测定数据对化合物混杂性进行系统评估。
AAPS J. 2013 Jul;15(3):808-15. doi: 10.1208/s12248-013-9488-0. Epub 2013 Apr 19.
4
Compound promiscuity: what can we learn from current data?化合物混杂性:我们能从现有数据中学到什么?
Drug Discov Today. 2013 Jul;18(13-14):644-50. doi: 10.1016/j.drudis.2013.03.002. Epub 2013 Mar 22.
5
Influence of search parameters and criteria on compound selection, promiscuity, and pan assay interference characteristics.搜索参数和标准对化合物选择、混杂性和泛分析干扰特征的影响。
J Chem Inf Model. 2014 Nov 24;54(11):3056-66. doi: 10.1021/ci5005509. Epub 2014 Oct 31.
6
Chemotography for multi-target SAR analysis in the context of biological pathways.基于生物通路的多靶标 SAR 分析的化学探测法。
Bioorg Med Chem. 2012 Sep 15;20(18):5416-27. doi: 10.1016/j.bmc.2012.02.034. Epub 2012 Feb 20.
7
Determining the Degree of Promiscuity of Extensively Assayed Compounds.确定广泛检测化合物的混杂程度。
PLoS One. 2016 Apr 15;11(4):e0153873. doi: 10.1371/journal.pone.0153873. eCollection 2016.
8
Analyzing compound activity records and promiscuity degrees in light of publication statistics.根据发表统计数据分析化合物活性记录和混杂程度。
F1000Res. 2016 Jun 6;5. doi: 10.12688/f1000research.8792.2. eCollection 2016.
9
Matched molecular pair analysis of small molecule microarray data identifies promiscuity cliffs and reveals molecular origins of extreme compound promiscuity.小分子微阵列数据的匹配分子对分析确定了混杂峭壁,并揭示了极端化合物混杂性的分子起源。
J Med Chem. 2012 Nov 26;55(22):10220-8. doi: 10.1021/jm301292a. Epub 2012 Oct 22.
10
Protein promiscuity: drug resistance and native functions--HIV-1 case.蛋白质的多特异性:耐药性与天然功能——以HIV-1为例
J Biomol Struct Dyn. 2005 Jun;22(6):615-24. doi: 10.1080/07391102.2005.10531228.

引用本文的文献

1
Papyrus: a large-scale curated dataset aimed at bioactivity predictions.纸莎草纸:一个旨在进行生物活性预测的大规模精选数据集。
J Cheminform. 2023 Jan 6;15(1):3. doi: 10.1186/s13321-022-00672-x.
2
Prediction of Anti-Glioblastoma Drug-Decorated Nanoparticle Delivery Systems Using Molecular Descriptors and Machine Learning.基于分子描述符和机器学习预测抗脑胶质瘤药物修饰的纳米粒子递药系统。
Int J Mol Sci. 2021 Oct 26;22(21):11519. doi: 10.3390/ijms222111519.
3
Prediction of Antimalarial Drug-Decorated Nanoparticle Delivery Systems with Random Forest Models.
基于随机森林模型的抗疟药物修饰纳米颗粒递送系统预测
Biology (Basel). 2020 Jul 30;9(8):198. doi: 10.3390/biology9080198.
4
An up-to-date overview of computational polypharmacology in modern drug discovery.计算药物多靶性在现代药物发现中的最新概述。
Expert Opin Drug Discov. 2020 Sep;15(9):1025-1044. doi: 10.1080/17460441.2020.1767063. Epub 2020 May 26.
5
Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set.超越炒作:使用ChEMBL生物活性基准集,深度神经网络优于现有方法。
J Cheminform. 2017 Aug 14;9(1):45. doi: 10.1186/s13321-017-0232-0.
6
VB-MK-LMF: fusion of drugs, targets and interactions using variational Bayesian multiple kernel logistic matrix factorization.VB-MK-LMF:使用变分贝叶斯多核逻辑矩阵分解融合药物、靶点及相互作用
BMC Bioinformatics. 2017 Oct 4;18(1):440. doi: 10.1186/s12859-017-1845-z.
7
Computational polypharmacology analysis of the heat shock protein 90 interactome.热休克蛋白90相互作用组的计算多药理学分析。
J Chem Inf Model. 2015 Mar 23;55(3):676-86. doi: 10.1021/ci5006959. Epub 2015 Feb 23.
8
Exploring compound promiscuity patterns and multi-target activity spaces.探索化合物多配体模式和多靶点活性空间。
Comput Struct Biotechnol J. 2014 Jan 29;9:e201401003. doi: 10.5936/csbj.201401003. eCollection 2014.
9
Molecular modeling reveals the novel inhibition mechanism and binding mode of three natural compounds to staphylococcal α-hemolysin.分子建模揭示了三种天然化合物抑制葡萄球菌α-溶血素的新机制和结合模式。
PLoS One. 2013 Nov 27;8(11):e80197. doi: 10.1371/journal.pone.0080197. eCollection 2013.
10
Comparability of mixed IC₅₀ data - a statistical analysis.混合 IC₅₀ 数据的可比性——统计分析。
PLoS One. 2013 Apr 16;8(4):e61007. doi: 10.1371/journal.pone.0061007. Print 2013.